Alstonine is primarily studied for its potential antipsychotic properties. It has shown activity in models related to schizophrenia, where it demonstrates effects similar to established antipsychotic drugs without causing significant motor side effects. This makes it a compound of interest in the development of new treatments for psychiatric disorders. Research also suggests that alstonine may influence serotonergic systems, particularly interacting with 5-HT2 receptors, which play a role in mood regulation. Due to its natural origin and observed bioactivity, it serves as a lead compound in neuropharmacology for exploring novel mechanisms in mental health therapy.